We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 81-100 of 306 results
  1. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis

    Background

    The TNM system is used to assess prognosis after colorectal cancer (CRC) diagnosis. Other prognostic factors reported include...

    Magnus I. Magnusson, Bjarni A. Agnarsson, ... Kari Stefansson in British Journal of Cancer
    Article Open access 18 August 2023
  2. Gene expression and immune infiltration in melanoma patients with different mutation burden

    Background

    Immunotherapy is a vital component in cancer treatment. However, due to the complex genetic bases of cancer, a clear prediction index for...

    Liwei Wang, Fu Chen, ... Zhengjian Yan in BMC Cancer
    Article Open access 09 April 2021
  3. Spatial distribution pattern of immune cells is associated with patient prognosis in colorectal cancer

    Background

    The spatial context of tumor-infiltrating immune cells (TIICs) is important in predicting colorectal cancer (CRC) patients’ clinical...

    Rongfang Shen, Ying Huang, ... Lin Feng in Journal of Translational Medicine
    Article Open access 01 July 2024
  4. Artificial intelligence for quantifying immune infiltrates interacting with stroma in colorectal cancer

    Background

    We proposed an artificial intelligence-based immune index, Deep-immune score, quantifying the infiltration of immune cells interacting with...

    **g Yang, Huifen Ye, ... Zaiyi Liu in Journal of Translational Medicine
    Article Open access 04 October 2022
  5. Overview of Basic Immunology and Clinical Application

    Tumor exists as a complex network of structures with an ability to evolve and evade the host immune surveillance mechanism. The immune milieu which...
    Bettzy Stephen, Joud Hajjar in Immunotherapy
    Chapter 2020
  6. The inflammatory pathogenesis of colorectal cancer

    The mutational landscape of colorectal cancer (CRC) does not enable predictions to be made about the survival of patients or their response to...

    Mark Schmitt, Florian R. Greten in Nature Reviews Immunology
    Article 28 April 2021
  7. Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer

    Background

    Bladder cancer (BC) is one of the most common malignant diseases and the most common causes of cancer death worldwide. Immunotherapy has...

    Pengyu Hui, Feng Ni, ... Zhe Wang in BMC Cancer
    Article Open access 18 April 2023
  8. DeepRisk network: an AI-based tool for digital pathology signature and treatment responsiveness of gastric cancer using whole-slide images

    Background

    Digital histopathology provides valuable information for clinical decision-making. We hypothesized that a deep risk network (DeepRisk)...

    Mengxin Tian, Zhao Yao, ... Xuefei Wang in Journal of Translational Medicine
    Article Open access 19 February 2024
  9. Hypoxia and the phenomenon of immune exclusion

    Over the last few years, cancer immunotherapy experienced tremendous developments and it is nowadays considered a promising strategy against many...

    Violena Pietrobon, Francesco M. Marincola in Journal of Translational Medicine
    Article Open access 06 January 2021
  10. ISG15 targets glycosylated PD-L1 and promotes its degradation to enhance antitumor immune effects in lung adenocarcinoma

    Background

    Immunocheckpoint inhibitors (ICIs) have been widely used in the clinical treatment of lung cancer. Although clinical studies and trials...

    Tongyuan Qu, Wenshuai Zhang, ... Wenfeng Cao in Journal of Translational Medicine
    Article Open access 22 May 2023
  11. Glucose transporter 3 (GLUT3) promotes lactylation modifications by regulating lactate dehydrogenase A (LDHA) in gastric cancer

    Objectives

    Glucose transporter 3 (GLUT3) plays a major role in glycolysis and glucose metabolism in cancer cells. We aimed to investigate the...

    Hao Yang, Shifeng Yang, ... Boshi Sun in Cancer Cell International
    Article Open access 01 December 2023
  12. Enlarged tumour-draining lymph node with immune-activated profile predict favourable survival in non-metastatic colorectal cancer

    Background

    The tumour-draining lymph node (TDLN) plays a pivotal role in the suppression of malignant tumour, however, the immunological profile and...

    Xu Guan, Pu Cheng, ... **shan Wang in British Journal of Cancer
    Article 13 November 2023
  13. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma

    Background

    Clear cell renal cell carcinoma (ccRCC) is an immunologically and histologically diverse tumor. However, how the structural heterogeneity...

    Dawei Zhang, Yuanli Ni, ... Zhansong Zhou in Journal of Translational Medicine
    Article Open access 20 July 2023
  14. Enhanced Tumoral MLH1-Expression in MLH1-/PMS2-Deficient Colon Cancer Is Indicative of Sporadic Colon Cancer and Not HNPCC

    Hereditary Non-Polyposis Colorectal Cancer (HNPCC) is caused by germline mutations of mismatch-repair (MMR) genes MLH1, MSH2, MSH6 and PMS2....

    María Tarancón-Diez, Reinhard Büttner, Nicolaus Friedrichs in Pathology & Oncology Research
    Article 06 January 2019
  15. Deep Learning for Histopathological Image Analysis

    Anatomical Pathology dates back to the nineteenth century when Rudolf Virchow introduced his concept of cellular pathology and when the technical...
    Cédric Wemmert, Jonathan Weber, ... Germain Forestier in Deep Learning for Biomedical Data Analysis
    Chapter 2021
  16. Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology

    Solid tumors have a dynamic ecosystem in which malignant and non-malignant (endothelial, stromal, and immune) cell types constantly interact....

    Yaël Glasson, Laure-Agnès Chépeaux, ... Henri-Alexandre Michaud in Seminars in Immunopathology
    Article Open access 04 January 2023
  17. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma

    Background

    TAP1 is an immunomodulation-related protein that plays different roles in various malignancies. This study investigated the transcriptional...

    Ru Zhu, Yu-Ting Chen, ... Ming-Chang Zhang in BMC Cancer
    Article Open access 11 February 2023
  18. Pathobionts in the tumour microbiota predict survival following resection for colorectal cancer

    Background and aims

    The gut microbiota is implicated in the pathogenesis of colorectal cancer (CRC). We aimed to map the CRC mucosal microbiota and...

    James L. Alexander, Joram M. Posma, ... James Kinross in Microbiome
    Article Open access 08 May 2023
  19. Patient stratification based on urea cycle metabolism for exploration of combination immunotherapy in colon cancer

    Background

    Owing to the low ratio of patients benefitting from immunotherapy, patient stratification becomes necessary. An accurate patient...

    Zirui Zhao, Haohan Liu, ... Jianbo Xu in BMC Cancer
    Article Open access 13 August 2022
  20. Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers

    Mesenchymal gastrointestinal cancers are represented by the gastrointestinal stromal tumors (GISTs) which occur throughout the whole gastrointestinal...

    Bo Li, Hui Chen, ... Changhua Zhang in Molecular Cancer
    Article Open access 18 April 2023
Did you find what you were looking for? Share feedback.